NEW YORK (Reuters Health) - A drug dubbed CX717, made by Cortex Pharmaceuticals, Irvine, California, reverses the biological and behavioral effects of sleep deprivation, according to results of animal studies. In an article in the research journal PLoS Biology, Dr. Sam A. Deadwyler and his associates propose that CX717 would particularly benefit individuals affected by extended work hours or night shifts. To test this possibility, they taught monkeys to perform a "delayed-match-to-sample task," in which they were presented with a single image on a computer screen, then would use a cursor to identify that image in a group of several...
